Wordt geladen...
Beyond The Needle: Biotech’s Delivery Challenge
Finding new ways to administer biologics could lead to higher patient acceptance and lower costs, and prove crucial as biotech companies release products aimed at more prevalent diseases. Here’s a look at the emerging world of noninjectable biologics.
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioCommunications LLC
2004
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3564283/ https://ncbi.nlm.nih.gov/pubmed/23390391 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|